Sources | Names Used |
---|---|
CTRPv2 | selumetinib:PLX-4032 (8:1 mol/mol) |
PharmacoGx | selumetinib:PLX-4032 (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CTAGE8 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | ZFHX2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | ATXN7L1 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | NIPAL1 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0006 |
mRNA | HMG20B | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
mRNA | C19orf35 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
mRNA | CHD8 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | TPT1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | FGFR1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | NEIL3 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |